Rhabdomyosarcoma of the temporal bone.
The temporal bone is the primary site for approximately 10% of rhabdomyosarcomas of the head and neck in children. Until recently it has been a uniformly fatal tumor despite treatment with radical surgery and radiation therapy. Although experience with the Intergroup Rhabdomyosarcoma Study protocol-II is of relatively short duration, treatment of these children with radiation therapy and multiple-drug intravenous and intrathecal chemotherapy holds promise of significantly improved control rates.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D012208:Rhabdomyosarcoma / Q000000981:diagnostic imaging / Q000628:therapy*; D012888:Skull Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D013701:Temporal Bone; D014057:Tomography, X-Ray Computed